Martyn Gibson, FCCA
Chief Financial Officer
As Symetria’s Chief Financial Officer, Martyn is responsible for all aspects of finance and accounting, IS infrastructure, strategic planning and forecasting, revenue and cash flow management.
Martyn joined Symetria following 12 years with Reckitt Benckiser Pharmaceuticals Inc. (now Indivior plc) supporting the commercialization and manufacture of Suboxone®, Subutex® and Buprenex®. Martyn served as Global Head of Finance for the division, with responsibilities including strategic planning, supply chain management and IS as part of the founding commercial leadership team.
Martyn has Fellowship designation from the Association of Chartered Certified Accountants (ACCA). Since 2008 has been an Honorary Board Member and Treasurer of a non-profit organization offering substance use disorder treatment services.
Get Help Fighting Opioid Addiction Today
If you’ve been worried about a loved one, or if you’re concerned about the way you use your pain medication, we urge you to contact us as soon as possible for help. To take the first step, contact us online or call right away.
Symetria Recovery’s success rate is 4x greater than the industry average.
After six months, 9 in 10 patients are having success in treatment.
Only 13% of patients returned to use of addictive substances at one year follow up.
99% of patients did not require admission to a higher level of care than we offer onsite.
The proof is in the numbers